Allergan To Pay Teva $700M To End Working-Capital Dispute
Allergan plc agreed Wednesday to pay Teva Pharmaceutical Industries Ltd. $700 million to end the drugmakers' dispute over the amount of working capital Teva received as part of its agreement to...To view the full article, register now.
Already a subscriber? Click here to view full article